Confirming DLC1

被引：0
|
作者：
Safia Ali Danovi
机构：
来源：
Nature Reviews Cancer | 2008年 / 8卷 / 7期
关键词：
D O I：
10.1038/nrc2425
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：487 / 487
相关论文
共 50 条
  • [21] Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas
    Bujko, M.
    Kober, P.
    Rusetska, N.
    Wakua, M.
    Goryca, K.
    Grecka, E.
    Matyja, E.
    Neska, J.
    Mandat, T.
    Bonicki, W.
    Siedlecki, J. A.
    JOURNAL OF NEURO-ONCOLOGY, 2016, 130 (03) : 473 - 484
  • [22] 鼻咽癌DLC1基因的表达研究
    彭宏
    赵彤
    姚开泰
    中华耳鼻咽喉科杂志, 2002, (06) : 57 - 60+105
  • [23] An oncogenic role of Deleted in Liver Cancer 1 (DLC1) in metastatic melanoma
    Yang, Xintao
    Cheung, May
    Lung, Hong-Lok
    Cheung, Martin
    CANCER RESEARCH, 2018, 78 (13)
  • [24] CDK5 is a major regulator of the tumor suppressor DLC1
    Tripathi, Brajendra K.
    Qian, Xiaolan
    Mertins, Philipp
    Wang, Dunrui
    Papageorge, Alex G.
    Carr, Steven A.
    Lowy, Douglas R.
    JOURNAL OF CELL BIOLOGY, 2014, 207 (05): : 627 - 642
  • [25] History dependent mechanical response of talin and its interaction to DLC1
    Dahal, Narayan
    Sharma, Sabita
    Phan, Binh
    Eis, Annie
    Popa, Ionel
    BIOPHYSICAL JOURNAL, 2022, 121 (03) : 533A - 533A
  • [26] Overexpressed DLC1 as target for breast cancer cell shape and survival
    不详
    CANCER BIOLOGY & THERAPY, 2004, 3 (07) : 587 - 588
  • [27] Prognostic Impact of DLC1 in ER-Positive Breast Cancer
    Gokmen-Polar, Yesim
    Gu, Xiaoping
    Nallamothu, Gouthami
    Badve, Sunil
    MODERN PATHOLOGY, 2015, 28 : 47A - 47A
  • [28] DLC1在肿瘤中的研究进展
    李斌
    海南医学, 2016, (05) : 792 - 795
  • [29] Prognostic Impact of DLC1 in ER-Positive Breast Cancer
    Gokmen-Polan, Yesim
    Gu, Xiaoping
    Nallamothu, Gouthami
    Badve, Sunil
    LABORATORY INVESTIGATION, 2015, 95 : 47A - 47A
  • [30] DLC1在肿瘤进程中的新角色
    王宇峰
    生命科学, 2014, 26 (08) : 779 - 781
12345